Skip to main content
TipRanks
Go Ultimate75% OFF

Susan Mahony Insider Profile

4 Followers

Susan Mahony, Director at Axsome Therapeutics, holds 829.00 shares in Axsome Therapeutics (Ticker: AXSM), holds 0.00 shares in Horizon Therapeutics (Ticker: HZNP), holds 46.61K shares in Eli Lilly & Co (Ticker: LLY).

Susan Mahony's Trading History

AXSM
Axsome Therapeutics
Jun 10, 2026DirectorUninformative Buy194.93K$111.09K
HZNP
Horizon Therapeutics
Oct 06, 2023―Uninformative Sell2.17M$0.00
LLY
Eli Lilly & Co
Apr 17, 2018SVP & Pres., Lilly OncologyUninformative Sell1.81M$64.45M
ZYME
Zymeworks
―Director――
ASMB
Assembly Biosciences
―Director――

You May Also Like

Susan Mahony insider profile FAQ

What is the percentage of profitable transactions made by Susan Mahony?
The percentage of profitable transactions made by Susan Mahony is 0%.
What is the average return per transaction made by Susan Mahony?
The average return per transaction made by Susan Mahony is -19.50%.
What stocks does Susan Mahony hold?
Susan Mahony holds: AXSM, LLY, HZNP, ASMB, ZYME stocks.
What was Susan Mahony’s latest transaction?
Susan Mahony’s latest transaction was an Uninformative Buy of $194.93K.
What was Susan Mahony's most profitable transaction?
Susan Mahony’s most profitable transaction was an Informative Sell of LLY stock on July 29, 2015. The return on the trade was 0.00%.
What is Susan Mahony's role in Axsome Therapeutics?
Susan Mahony's role in Axsome Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.